BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of BAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹13 Cr |
How is Contingent Liabilities of BAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 0.83 | |
| Mar2024 | ₹17 Cr | 3.16 | |
| Mar2023 | ₹16 Cr | 1.18 | |
| Mar2022 | ₹16 Cr | 25.01 | |
| Mar2021 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹112.1 Cr | -0.8% | -3.9% | -38.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -0.8% |
-3.9% |
-38.9% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses